Sample Request

Global Breast Cancer Liquid Biopsy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

SELECT LICENSE:

Published on 09/10/2020| Code: MAR41115D| Category: Utilities| Total Pages: 125

The Breast Cancer Liquid Biopsy market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Breast Cancer Liquid Biopsy market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Breast Cancer Liquid Biopsy market. The report focuses on well-known providers in the global Breast Cancer Liquid Biopsy industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Breast Cancer Liquid Biopsy Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Breast Cancer Liquid Biopsy market covered in Chapter 4:

FLUXION BIOSCIENCES
Isogen Life Science
Cynvenio Biosystems, Inc
Menarini Silicon Biosystems
Genomic Health
GUARDANT HEALTH, INC
Thermo Fisher Scientific Inc
Illumina, Inc
Biodesix, Inc
Myriad Genetics, Inc

In Chapter 11 and 13.3, on the basis of types, the Breast Cancer Liquid Biopsy market from 2015 to 2026 is primarily split into:

Circulating Tumor Cells (CTCs)
Cell-free DNA (cfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers

In Chapter 12 and 13.4, on the basis of applications, the Breast Cancer Liquid Biopsy market from 2015 to 2026 covers:

Reference Laboratories
Hospitals and Physician Laboratories
Other End Users

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Breast Cancer Liquid Biopsy Market Share by Type (2020-2026)

1.5.2 Circulating Tumor Cells (CTCs)
1.5.3 Cell-free DNA (cfDNA)
1.5.4 Extracellular Vesicles (EVs)
1.5.5 Other Circulating Biomarkers
1.6 Market by Application

1.6.1 Global Breast Cancer Liquid Biopsy Market Share by Application (2020-2026)

1.6.2 Reference Laboratories
1.6.3 Hospitals and Physician Laboratories
1.6.4 Other End Users
1.7 Breast Cancer Liquid Biopsy Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Breast Cancer Liquid Biopsy Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter’s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Breast Cancer Liquid Biopsy Market

3.1 Value Chain Status

3.2 Breast Cancer Liquid Biopsy Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Breast Cancer Liquid Biopsy

3.2.3 Labor Cost of Breast Cancer Liquid Biopsy

3.2.3.1 Labor Cost of Breast Cancer Liquid Biopsy Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 FLUXION BIOSCIENCES
4.1.1 FLUXION BIOSCIENCES Basic Information
4.1.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.1.3 FLUXION BIOSCIENCES Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.1.4 FLUXION BIOSCIENCES Business Overview
4.2 Isogen Life Science
4.2.1 Isogen Life Science Basic Information
4.2.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.2.3 Isogen Life Science Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.2.4 Isogen Life Science Business Overview
4.3 Cynvenio Biosystems, Inc
4.3.1 Cynvenio Biosystems, Inc Basic Information
4.3.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.3.3 Cynvenio Biosystems, Inc Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.3.4 Cynvenio Biosystems, Inc Business Overview
4.4 Menarini Silicon Biosystems
4.4.1 Menarini Silicon Biosystems Basic Information
4.4.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.4.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.4.4 Menarini Silicon Biosystems Business Overview
4.5 Genomic Health
4.5.1 Genomic Health Basic Information
4.5.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.5.3 Genomic Health Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.5.4 Genomic Health Business Overview
4.6 GUARDANT HEALTH, INC
4.6.1 GUARDANT HEALTH, INC Basic Information
4.6.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.6.3 GUARDANT HEALTH, INC Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.6.4 GUARDANT HEALTH, INC Business Overview
4.7 Thermo Fisher Scientific Inc
4.7.1 Thermo Fisher Scientific Inc Basic Information
4.7.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.7.3 Thermo Fisher Scientific Inc Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.7.4 Thermo Fisher Scientific Inc Business Overview
4.8 Illumina, Inc
4.8.1 Illumina, Inc Basic Information
4.8.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.8.3 Illumina, Inc Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.8.4 Illumina, Inc Business Overview
4.9 Biodesix, Inc
4.9.1 Biodesix, Inc Basic Information
4.9.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.9.3 Biodesix, Inc Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.9.4 Biodesix, Inc Business Overview
4.10 Myriad Genetics, Inc
4.10.1 Myriad Genetics, Inc Basic Information
4.10.2 Breast Cancer Liquid Biopsy Product Profiles, Application and Specification
4.10.3 Myriad Genetics, Inc Breast Cancer Liquid Biopsy Market Performance (2015-2020)
4.10.4 Myriad Genetics, Inc Business Overview

5 Global Breast Cancer Liquid Biopsy Market Analysis by Regions

5.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Regions

5.1.1 Global Breast Cancer Liquid Biopsy Sales by Regions (2015-2020)

5.1.2 Global Breast Cancer Liquid Biopsy Revenue by Regions (2015-2020)

5.2 North America Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

5.3 Europe Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

5.6 South America Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

6 North America Breast Cancer Liquid Biopsy Market Analysis by Countries

6.1 North America Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

6.1.1 North America Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)

6.1.2 North America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)

6.1.3 North America Breast Cancer Liquid Biopsy Market Under COVID-19

6.2 United States Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

6.2.1 United States Breast Cancer Liquid Biopsy Market Under COVID-19

6.3 Canada Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

6.4 Mexico Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

7 Europe Breast Cancer Liquid Biopsy Market Analysis by Countries

7.1 Europe Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

7.1.1 Europe Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)

7.1.2 Europe Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)

7.1.3 Europe Breast Cancer Liquid Biopsy Market Under COVID-19

7.2 Germany Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

7.2.1 Germany Breast Cancer Liquid Biopsy Market Under COVID-19

7.3 UK Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

7.3.1 UK Breast Cancer Liquid Biopsy Market Under COVID-19

7.4 France Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

7.4.1 France Breast Cancer Liquid Biopsy Market Under COVID-19

7.5 Italy Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

7.5.1 Italy Breast Cancer Liquid Biopsy Market Under COVID-19

7.6 Spain Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

7.6.1 Spain Breast Cancer Liquid Biopsy Market Under COVID-19

7.7 Russia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

7.7.1 Russia Breast Cancer Liquid Biopsy Market Under COVID-19

8 Asia-Pacific Breast Cancer Liquid Biopsy Market Analysis by Countries

8.1 Asia-Pacific Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Under COVID-19

8.2 China Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

8.2.1 China Breast Cancer Liquid Biopsy Market Under COVID-19

8.3 Japan Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

8.3.1 Japan Breast Cancer Liquid Biopsy Market Under COVID-19

8.4 South Korea Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

8.4.1 South Korea Breast Cancer Liquid Biopsy Market Under COVID-19

8.5 Australia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

8.6 India Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

8.6.1 India Breast Cancer Liquid Biopsy Market Under COVID-19

8.7 Southeast Asia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Breast Cancer Liquid Biopsy Market Under COVID-19

9 Middle East and Africa Breast Cancer Liquid Biopsy Market Analysis by Countries

9.1 Middle East and Africa Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Breast Cancer Liquid Biopsy Market Under COVID-19

9.2 Saudi Arabia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

9.3 UAE Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

9.4 Egypt Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

9.5 Nigeria Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

9.6 South Africa Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

10 South America Breast Cancer Liquid Biopsy Market Analysis by Countries

10.1 South America Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

10.1.1 South America Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)

10.1.2 South America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)

10.1.3 South America Breast Cancer Liquid Biopsy Market Under COVID-19

10.2 Brazil Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

10.2.1 Brazil Breast Cancer Liquid Biopsy Market Under COVID-19

10.3 Argentina Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

10.4 Columbia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

10.5 Chile Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)

11 Global Breast Cancer Liquid Biopsy Market Segment by Types

11.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Breast Cancer Liquid Biopsy Sales and Market Share by Types (2015-2020)

11.1.2 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Types (2015-2020)

11.2 Circulating Tumor Cells (CTCs) Sales and Price (2015-2020)
11.3 Cell-free DNA (cfDNA) Sales and Price (2015-2020)
11.4 Extracellular Vesicles (EVs) Sales and Price (2015-2020)
11.5 Other Circulating Biomarkers Sales and Price (2015-2020)

12 Global Breast Cancer Liquid Biopsy Market Segment by Applications

12.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Breast Cancer Liquid Biopsy Sales and Market Share by Applications (2015-2020)

12.1.2 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Applications (2015-2020)

12.2 Reference Laboratories Sales, Revenue and Growth Rate (2015-2020)
12.3 Hospitals and Physician Laboratories Sales, Revenue and Growth Rate (2015-2020)
12.4 Other End Users Sales, Revenue and Growth Rate (2015-2020)

13 Breast Cancer Liquid Biopsy Market Forecast by Regions (2020-2026)

13.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2020-2026)

13.2 Breast Cancer Liquid Biopsy Market Forecast by Regions (2020-2026)

13.2.1 North America Breast Cancer Liquid Biopsy Market Forecast (2020-2026)

13.2.2 Europe Breast Cancer Liquid Biopsy Market Forecast (2020-2026)

13.2.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Forecast (2020-2026)

13.2.4 Middle East and Africa Breast Cancer Liquid Biopsy Market Forecast (2020-2026)

13.2.5 South America Breast Cancer Liquid Biopsy Market Forecast (2020-2026)

13.3 Breast Cancer Liquid Biopsy Market Forecast by Types (2020-2026)

13.4 Breast Cancer Liquid Biopsy Market Forecast by Applications (2020-2026)

13.5 Breast Cancer Liquid Biopsy Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect
3 Hunters Talent Solutions LATAM
Atelerix Life Sciences Inc
David Clark
DSGLOBAL CO.,LTD.
Hitotsubashi University
kovis-group
Saunacore
Suez Consulting
WestRock
Medeon Biodesign
Power Transmission Consulting, PTC AB
Sint Maartenskliniek
ITW Specialty Films
American Fuji Seal, Inc.
Tag-consultants.com
HAZEMAG Systems GmbH
Dabur International
lippert componentrs
Aelea Commodities Private Limited
ERRIA A/S
Chiripal Group
Capstone Partners
VETTEX SRL
Ægir Advisory Services
John Deere
ADTEC Plasma Technology
Cairneagle
Mckinsey
Panasonic Consumer Electronics Company
ACT
Mele & Co
SAZKA a.s.
THIN
Assurance Services International
Intro-act Inc
School of Health Sciences/Democritus University of Thrace
W.L.Gore
Nippon Steel Co.
AFB International
986 Labs
Bamboi
Zaptin Communications LLC
DONGIL MACHINERY
GABALabs
Salon IQ
SW Umwelttechnik Stoiser & Wolschner AG
RSM Dahman Auditors
DentalMonitoring
Emosis Diagnostics
 CDA InterCorp
Lanhe USA, Inc
SMP
Vibes
Tenshi Life Sciences
Simac Masic
CedarBridge
FedEx Express
Chonnam National University
GE Renewable Energy
Crosby Group
Molecular Health
Bauerfeind
TPE HEALTHCARE SDN. BHD.
3 Digity
PHC Holdings Corporation

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005